Therefore, Treg-specific CD36 knockout or treatment with a function-blocking antibody suppressed tumor growth and promoted anti-tumor immunity, which was even more pronounced when it was combined with an immune checkpoint inhibitor, such as an anti-PD-1 antibody [56]. The gene discussed is CD36; the disease is neoplasm.